Insider Selling: Axon Enterprise, Inc. (NASDAQ:AXON) Director Sells 900 Shares of Stock

Axon Enterprise, Inc. (NASDAQ:AXON) Director Julie A. Cullivan sold 900 shares of Axon Enterprise stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $353.53, for a total value of $318,177.00. Following the completion of the transaction, the director now owns 3,653 shares of the company’s stock, valued at approximately $1,291,445.09. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.

Axon Enterprise Stock Performance

NASDAQ AXON traded down $0.24 during trading hours on Friday, hitting $354.62. The company had a trading volume of 509,146 shares, compared to its average volume of 518,284. The company has a debt-to-equity ratio of 0.35, a quick ratio of 2.52 and a current ratio of 2.88. Axon Enterprise, Inc. has a 1-year low of $189.12 and a 1-year high of $378.89. The company has a market cap of $26.76 billion, a PE ratio of 102.36, a price-to-earnings-growth ratio of 9.78 and a beta of 0.95. The business has a 50 day moving average of $330.20 and a 200-day moving average of $310.26.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings data on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.02 by $0.18. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. The company had revenue of $504.00 million during the quarter, compared to the consensus estimate of $478.35 million. During the same quarter in the prior year, the firm posted $0.80 earnings per share. Axon Enterprise’s revenue for the quarter was up 34.5% on a year-over-year basis. As a group, equities research analysts expect that Axon Enterprise, Inc. will post 1.79 EPS for the current year.

Institutional Investors Weigh In On Axon Enterprise

Hedge funds have recently made changes to their positions in the business. ICA Group Wealth Management LLC acquired a new stake in shares of Axon Enterprise during the fourth quarter worth about $26,000. Blue Trust Inc. boosted its stake in shares of Axon Enterprise by 987.5% during the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after buying an additional 79 shares during the period. Trivant Custom Portfolio Group LLC acquired a new stake in shares of Axon Enterprise during the first quarter worth about $31,000. First PREMIER Bank acquired a new stake in shares of Axon Enterprise during the first quarter worth about $33,000. Finally, Blue Bell Private Wealth Management LLC acquired a new stake in shares of Axon Enterprise during the first quarter worth about $41,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently weighed in on AXON shares. Needham & Company LLC restated a “buy” rating and issued a $400.00 price target on shares of Axon Enterprise in a research note on Wednesday, August 7th. Robert W. Baird lifted their price objective on Axon Enterprise from $355.00 to $360.00 and gave the stock an “outperform” rating in a report on Wednesday, August 7th. Barclays lifted their price objective on Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. Craig Hallum lifted their price objective on Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a report on Wednesday, August 7th. Finally, Jefferies Financial Group began coverage on Axon Enterprise in a report on Wednesday, July 17th. They issued a “buy” rating and a $385.00 price objective on the stock. Two research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $358.08.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.